Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
I think it is fair to say that was the best speech I have seen David Cameron give in the decade I have been reporting on him.
Former Manchester United defender Rio Ferdinand doesn't believe England will be successful until the FA and Premier League work together
Essex Police say that they can't comment on Martin Goldberg's death, but there were indications of an attempt to destroy evidence.